tiprankstipranks
Advertisement
Advertisement

INTS Stock Latest News

Intensity Therapeutics provides update in Invincicle-4 study
The FlyIntensity Therapeutics provides update in Invincicle-4 study
7d ago
INTS
Intensity Therapeutics Stockholders Approve Proposals at Annual Meeting
PremiumCompany Announcements
Intensity Therapeutics Stockholders Approve Proposals at Annual Meeting
1M ago
8K
INTS
Intensity Therapeutics reports Q1 EPS (96c), consensus ($1.09)
PremiumThe Fly
Intensity Therapeutics reports Q1 EPS (96c), consensus ($1.09)
3M ago
INTS
Intensity Therapeutics upgraded to Buy from Hold at Freedom Broker
PremiumThe Fly
Intensity Therapeutics upgraded to Buy from Hold at Freedom Broker
4M ago
INTS
U.S. Tariff and Trade Policy Risks Threaten Intensity Therapeutics’ Supply Chain, Costs, and Stock Valuation
PremiumCompany Announcements
U.S. Tariff and Trade Policy Risks Threaten Intensity Therapeutics’ Supply Chain, Costs, and Stock Valuation
4M ago
INTS
Intensity Therapeutics issued new patent in the US
PremiumThe FlyIntensity Therapeutics issued new patent in the US
4M ago
INTS
Intensity Therapeutics Expands ATM Equity Offering Capacity
Premium
Company Announcements
Intensity Therapeutics Expands ATM Equity Offering Capacity
4M ago
8K
INTS
Intensity Therapeutics price target adjusted to $30 at Alliance Global
Premium
The Fly
Intensity Therapeutics price target adjusted to $30 at Alliance Global
4M ago
INTS
Intensity Therapeutics provides update on INVINCIBLE-4 Study
PremiumThe Fly
Intensity Therapeutics provides update on INVINCIBLE-4 Study
4M ago
INTS
Intensity Therapeutics, Inc. (INTS) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Intensity Therapeutics, Inc. (INTS) Q4 Earnings Cheat Sheet
4M ago
INTS
Intensity Therapeutics Regains Nasdaq Compliance, Stabilizing Market Listing
PremiumCompany Announcements
Intensity Therapeutics Regains Nasdaq Compliance, Stabilizing Market Listing
5M ago
8K
INTS
Intensity Therapeutics regains Nasdaq compliance
PremiumThe Fly
Intensity Therapeutics regains Nasdaq compliance
5M ago
INTS
Intensity Therapeutics Inc trading halted, news pending
PremiumThe FlyIntensity Therapeutics Inc trading halted, news pending
5M ago
INTS
Upcoming Stock Splits This Week (February 17 to February 20) – Stay Invested
Premium
Market News
Upcoming Stock Splits This Week (February 17 to February 20) – Stay Invested
5M ago
SMX
WTO
Intensity Therapeutics Announces 1-for-25 Reverse Stock Split
Premium
Company Announcements
Intensity Therapeutics Announces 1-for-25 Reverse Stock Split
5M ago
8K
INTS
Intensity Therapeutics announces reverse stock split
PremiumThe Fly
Intensity Therapeutics announces reverse stock split
5M ago
INTS
Intensity Therapeutics to ‘opportunistically raise additional capital’ in 2026
PremiumThe Fly
Intensity Therapeutics to ‘opportunistically raise additional capital’ in 2026
6M ago
INTS
Intensity Therapeutics to present two posters ay SABCS
PremiumThe Fly
Intensity Therapeutics to present two posters ay SABCS
7M ago
INTS
Intensity Therapeutics Granted Nasdaq Compliance Extension
PremiumCompany Announcements
Intensity Therapeutics Granted Nasdaq Compliance Extension
8M ago
8K
INTS
Intensity Therapeutics granted 180-day extension to regain Nasdaq compliance
PremiumThe FlyIntensity Therapeutics granted 180-day extension to regain Nasdaq compliance
8M ago
INTS
Intensity Therapeutics Expands At-The-Market Offering
Premium
Company Announcements
Intensity Therapeutics Expands At-The-Market Offering
8M ago
8K
INTS
Intensity Therapeutics Reports Q3 2025 Financial Results
Premium
Company Announcements
Intensity Therapeutics Reports Q3 2025 Financial Results
8M ago
INTS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >